Related references
Note: Only part of the references are listed.Preventing and controlling dyskinesia in Parkinson's disease - A view of current knowledge and future opportunities
Peter Jenner
MOVEMENT DISORDERS (2008)
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in Parkinsonian rats
Manolo Carta et al.
BRAIN (2007)
Transdermal rotigotine - Double-blind, placebo-controlled trial in Parkinson disease
Joseph Jankovic et al.
ARCHIVES OF NEUROLOGY (2007)
In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride):: A novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist
Jeffrey C. Glennon et al.
SYNAPSE (2006)
Early piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN study
Olivier Rascol et al.
MOVEMENT DISORDERS (2006)
Quality of life and depression in Parkinson's disease
Anette Schrag
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications
C. Warren Olanow et al.
LANCET NEUROLOGY (2006)
Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease
W Bara-Jimenez et al.
MOVEMENT DISORDERS (2005)
The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone:: evidence from preweanling rats
SA McDougall et al.
PSYCHOPHARMACOLOGY (2005)
Effect of pulsatile administration of levodopa on Dyskinesia induction in drug-naive MPTP-treated common marmosets: Effect of dose, frequency of administration, and brain exposure
LA Smith et al.
MOVEMENT DISORDERS (2003)
Sleep attacks in patients taking dopamine agonists: review
CN Homann et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
Pharmacology of dopamine agonists in the treatment of Parkinson's disease
P Jenner
NEUROLOGY (2002)
SLV308 -: Antiparkinsonian -: Antidepressant -: Anxiolytic -: Dopamine D2 partial agonist -: 5-HT1A agonist
R Feenstra et al.
DRUGS OF THE FUTURE (2001)
Sleep disorders in patients with Parkinson's disease - Epidemiology and management
JP Larsen et al.
CNS DRUGS (2001)
Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial
R Holloway et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Continuous dopamine-receptor stimulation in early Parkinson's disease
CW Olanow et al.
TRENDS IN NEUROSCIENCES (2000)
Continuous dopamine-receptor stimulation in advanced Parkinson's disease
JG Nutt et al.
TRENDS IN NEUROSCIENCES (2000)
Share Paper
